Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.88 |
| ▸ | MEN1 | O00255 | 2/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.84 |
| ▸ | ATM | Q13315 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | GNAI3 | P08754 | 8/20 | 0.56 |
| ▸ | GNAI1 | P63096 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 7/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150076 | 0.98 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL7837034 | 0.98 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534153 | 0.98 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL6466560 | 0.93 | L3MBTL1 (1.00) | L3MBTL1MEN1KMT2ATDP1ATM | |
| N-(Decanoyl)Pyrrolidine SCHEMBL10755236 | 0.91 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10494122 | 0.91 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL249052 | 0.91 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534171 | 0.91 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10290341 | 0.91 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10535931 | 0.91 | L3MBTL1 (1.00) | L3MBTL1MEN1KMT2ATDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110320294-A | A kind of detection method of 1- (4- fluorophenyl) -2- (N- pyrrolidinyl) -1- pentanone | 公安部物证鉴定中心 | 2019-10-11 | — | — | CN | claimed |
| CN-109777104-A | Aqueous polyether sulfone dispersion liquid and preparation method thereof | 深圳市夸克纳米材料有限公司 | 2019-05-21 | — | — | CN | claimed |
| CN-109415510-A | PAI-based coating composition | 西莫-戴顿有限责任公司 | 2019-03-01 | — | — | CN | claimed |
| CN-109415508-A | Full-size process for preparing polymer powders | 西莫-戴顿有限责任公司 | 2019-03-01 | — | — | CN | claimed |
| CN-106715616-A | Low toxicity solvent system for the manufacture of polyamideimide and polyamideamic acid resins | 富士胶片亨特化学制品美国有限公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106687540-A | Low toxicity solvent system for polyamideimide and polyamide amic acid resin coating | 富士胶片亨特化学制品美国有限公司 | 2017-05-17 | — | — | CN | claimed |
| US-12240862-B2 | Inhibitors of peptidylarginine deiminases | GILEAD SCIENCES, INC. (US) | 2025-03-04 | — | — | US | disclosed |
| CN-119161403-A | Application of oxime cholic acid analogue as TGR5 allosteric agonist | 常州大学 | 2024-12-20 | — | — | CN | disclosed |
| CN-118812618-A | Application of cholic acid analogue as TGR5 allosteric agonist | 常州大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-115710298-B | Cholic acid derivative, preparation method thereof and application of cholic acid derivative as TGR5 allosteric agonist | 常州大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-118724999-A | Synthesis of cholic acid derivative and application of cholic acid derivative as TGR5 allosteric agonist | 常州大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-115385902-B | Benzimidazole compound, and preparation method and application thereof | 徐州医科大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-117110457-A | Analysis method for screening 50 new pollutants in sewage by micro-volume direct sample injection technology | 司法鉴定科学研究院 | 2023-11-24 | — | — | CN | disclosed |
| US-5242919-A | Antiinflammatory agents or hypotensive agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-07 | — | — | US | disclosed |
| US-4837026-A | Transdermal and systemic preparation and method | THERAPEUTIC PATCH RESEARCH N.V. | 1989-06-06 | — | — | US | disclosed |
| EP-0240554-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA, Vithal J. (US) | 1987-10-14 | — | — | EP | disclosed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | disclosed |
| EP-0094052-A2 | 1-(1,3-Dioxolan-2-yl-methyl)-1H-imidazoles and -1H-1,2,4-triazoles and their salts, process for their preparation, compositions containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-11-16 | — | — | EP | disclosed |
| US-4105763-A | 1-Methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-08-08 | — | — | US | disclosed |
| US-4078086-A | Anthraquinone-bis-amidines and process for preparing them | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12240862-B2 | Inhibitors of peptidylarginine deiminases | PADI4, PADI2, PADI1 | L3MBTL1 2977/4885MEN1 2517/4885KMT2A 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.